Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDAPACHLOR: Indapamide and Chlorthalidone vs Hydrochlorothiazide for Kidney Stone Prevention
NCT06111885Phase 2Recruiting
- Sponsor
- Insel Gruppe
- Start
- Oct 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indapamide, chlorthalidone in nephrolithiasis, sponsored by Insel Gruppe. Started Oct 2024; status: recruiting.
02
Drugs
indapamidechlorthalidone
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT06111885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06111885.